Article (Scientific journals)
Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age.
Lagrou, K.; Vanderfaeillie, J.; Froidecoeur, Christelle et al.
2007In European Journal of Endocrinology, 156 (2), p. 195-201
Peer Reviewed verified by ORBi
 

Files


Full Text
Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age.pdf
Publisher postprint (454.44 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Body Height; Child; Child Behavior; Child Development/drug effects; Child, Preschool; Cognition/drug effects; Cohort Studies; Developmental Disabilities/drug therapy; Educational Status; Female; Human Growth Hormone/administration & dosage; Humans; Infant, Newborn; Infant, Small for Gestational Age; Intelligence Tests; Male; Psychology
Abstract :
[en] OBJECTIVE AND DESIGN: Children born small for gestational age (SGA) are not only at risk for short stature, but also for neurodevelopmental and behavioral problems. In this study, we analyzed the effects of high-dose GH therapy on cognitive development and psychosocial functioning in 34 prepubertal (3-8 years) short SGA children, equally randomized into a GH-treated group (TRG) and an untreated group (UTRG). METHODS: At start and after 2 years, children underwent standardized tests measuring the intellectual abilities (Wechsler Preschool and Primary Scale of Intelligence-Revised, or Wechsler Intelligence Scale for Children-Revised); their parents completed a standardized questionnaire evaluating psychosocial functioning (Child Behavior Checklist; CBCL). RESULTS: At start, total IQ scores were significantly (P < 0.05) lower in the SGA group than in the general population: 32% of the SGA patients had scores below 85. After 2 years, IQ scores remained unchanged in the TRG, but increased significantly (P < 0.05) in the UTRG. After exclusion of children with developmental problems, however, no significant changes in IQ scores occurred in the UTRG as well as the TRG. At baseline, 24% (8/34) children had problematic CBCL total problems scores, equally distributed among the two groups; no significant changes in the different subscale scores occurred after 2 years. CONCLUSION: No beneficial effect of 2 years of GH therapy on cognitive and behavioral profile could be observed in a cohort of rather young short SGA children presenting a variable degree of developmental delay and behavioral problems. Subsequent follow-up could reveal potential long-term effects of GH therapy on development and behavior.
Disciplines :
Pediatrics
Endocrinology, metabolism & nutrition
Author, co-author :
Lagrou, K.
Vanderfaeillie, J.
Froidecoeur, Christelle ;  Université de Liège > Département de personne et société > Psycho. de la délinquance et du développement psycho.
Thomas, M.
Massa, G.
Tenoutasse, S.
Craen, M.
LEBRETHON, Marie-Christine ;  Centre Hospitalier Universitaire de Liège - CHU > Pédiatrie
Beckers, D.
Francois, I.
Rooman, R.
Thiry-Counson, G.
de Beaufort, C.
De Schepper, J.
More authors (4 more) Less
Language :
English
Title :
Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age.
Publication date :
2007
Journal title :
European Journal of Endocrinology
ISSN :
0804-4643
eISSN :
1479-683X
Publisher :
BioScientifica, United Kingdom
Volume :
156
Issue :
2
Pages :
195-201
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 16 April 2015

Statistics


Number of views
45 (0 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
21
Scopus citations®
without self-citations
20
OpenCitations
 
13

Bibliography


Similar publications



Contact ORBi